• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo
- - - - -

Diagnoses Cancer and Produces the Drug


  • Please log in to reply
2 replies to this topic

#1 alex83

  • Guest
  • 119 posts
  • 1
  • Location:Israel

Posted 06 August 2004 - 10:18 PM


From the Weizman institute news release ( http://80.70.129.162...371&doc_id=3790 )

Biological Computer Diagnoses Cancer and Produces the Drug -- in a Test Tube
28.04.2004

Weizmann Institute scientist’s vision: Microscopic computers will function inside living tissues, performing diagnosis and administering treatment.

The world’s smallest computer (around a trillion can fit in a drop of water) might one day go on record again as the tiniest medical kit. Made entirely of biological molecules, this computer was successfully programmed to identify - in a test tube - changes in the balance of molecules in the body that indicate the presence of certain cancers, to diagnose the type of cancer, and to react by producing a drug molecule to fight the cancer cells.

The Weizmann Institute of Science team that developed the computer published these results today in Nature. Headed by Prof. Ehud Shapiro, of the Departments of Computer Sciences and Applied Mathematics, and Biological Chemistry, the team included research students Yaakov Benenson, Binyamin Gil, Uri Ben-Dor and Dr. Rivka Adar. Shapiro presented the team’s findings today at the Brussels symposium “Life, a Nobel Story,” in which Nobel Laureates and others addressed the future of the life sciences.

As in previous biological computers produced in Shapiro’s lab, input, output and “software” are all composed of DNA, the material of genes, while DNA-manipulating enzymes are used as “hardware.” The newest version’s input apparatus is designed to assess concentrations of specific RNA molecules, which may be overproduced or under produced, depending on the type of cancer. Using pre-programmed medical knowledge, the computer then makes its diagnosis based on the detected RNA levels. In response to a cancer diagnosis, the output unit of the computer can initiate the controlled release of a single-stranded DNA molecule that is known to interfere with the cancer cell’s activities, causing it to self-destruct.

In one series of test-tube experiments, the team programmed the computer to identify RNA molecules that indicate the presence of prostate cancer and, following a correct diagnosis, to release the short DNA strands designed to kill cancer cells. Similarly, they were able to identify, in the test tube, the signs of one form of lung cancer. One day in the future, they hope to create a “doctor in a cell”, which will be able to operate inside a living body, spot disease and apply the necessary treatment before external symptoms even appear.

The original version of the biomolecular computer (also created in a test tube) capable of performing simple mathematical calculations, was introduced by Shapiro and colleagues in 2001. An improved system, which uses its input DNA molecule as its sole source of energy, was reported in 2003 and was listed in the 2004 Guinness Book of World Records as the smallest biological computing device.

Shapiro: “It is clear that the road to realizing our vision is a long one; it may take decades before such a system operating inside the human body becomes reality. Nevertheless, only two years ago we predicted that it would take another 10 years to reach the point we have reached today.”

Further information and photos can be obtained online at: www.weizmann.ac.il/udi/PressRoom or by contacting the Weizmann Institute Publications and Media Relations Department at 972-8-934-3856.


Prof. Ehud Shapiro's research is supported by the M.D. Moross Institute for Cancer Research, the Samuel R. Dweck Foundation, the Dolfi and Lola Ebner Center for Biomedical Research, the Benjamin and Seema Pulier Charitable Foundation, and the Robert Rees Fund for Applied Research.

#2

  • Lurker
  • 1

Posted 06 August 2004 - 11:46 PM

These genetic constructs are also known as "smart genes" in that they are provided with a regulatory region designed to sense the presence of absence of a particular substrate which allows them control the expression of the protein the gene encodes for either by switching on or off (digital) or have a variable range of response based on the concentration of substrate (analog). Naturally a number of these smart genes can be constructed in such a way where they can interact with their own products as well as those of their environment leading to very sophisticated devices able to make reasonably complex decisions. Furthermore they can exist in quantities of billions in a test tube so the possibilities for the astute engineer are boundless.

I would dare say that if the I/O problem could be solved such a computational system could easily compete against any computer model that is available at the moment, especially since it could be constructed in hours(!).

Of particular application is in gene therapy where one wants to have controlled expression of the new gene(s) introduced rather than just constitutive expression.

#3 alex83

  • Topic Starter
  • Guest
  • 119 posts
  • 1
  • Location:Israel

Posted 07 August 2004 - 07:09 PM

Thanks for the explanation, I thought about doing my grad studies in Weitzman institute, I'm going there to look around in a couple of weeks, so I hope to finally start doing something useful soon ;)

sponsored ad

  • Advert



0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users